Position in DGX
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$2,155
+$1,720 QoQ
Shares Held
11
+266.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
4 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in DGX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026ALBION FINANCIAL GROUP /UT holds $13,117,631 across 9 Diagnostics & Research names. DGX ranks #6 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
24,328 | $11,957,941 | |
| 2 | A |
Agilent Technologies, Inc.
|
7,826 | $892,007 | |
| 3 | DHR |
Danaher Corp /De/
|
1,290 | $244,584 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
26 | $14,609 | |
| 5 | WAT |
Waters Corp /De/
|
15 | $4,467 | |
| 6 | DGX |
Quest Diagnostics Inc
This page
|
11 | $2,155 | |
| 7 | LH |
Labcorp Holdings Inc.
|
6 | $1,600 | |
| 8 | ILMN |
Illumina, Inc.
|
2 | $246 |
All Filings in DGX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,155 | 11 | Shares | Sole | 2026-04-27 | |
| 2021-09-30 | $435 | 3 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $395 | 3 | Shares | Sole | 2021-08-12 | |
| 2020-12-31 | $357 | 3 | Shares | Sole | 2021-02-19 | |
| No filing history on record for this holder in this stock. | ||||||